Home

Bradley L. Campbell, President and CEO: Amicus Therapeutics FOLD Sell · Filed 01/22

Trade details

Type
Insider sale
Amount
$1,073,250
Shares · price
75,000 sh · $14.31 a share
Held after
1,021,180 sh
Trade date
26/01/20
Filed
26/01/22
Days to filing
2 days

Sold 6.8% of holdings

Share of holding sold
6.8%

Amicus Therapeutics trades, last 26 weeks

What else happened in Amicus Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/21~02/19

Bradley L. Campbell's recent trades

  • Bradley L. Campbell

    Sell10b5-1 planAmicus Therapeutics

    $322.9K

    Filed 03/04

  • Bradley L. Campbell

    Sell10b5-1 planAmicus Therapeutics

    $846.3K

    Filed 25/12/17

  • Bradley L. Campbell

    Sell10b5-1 planAmicus Therapeutics

    $146K

    Filed 25/12/03

  • Bradley L. Campbell

    Sell10b5-1 planAmicus Therapeutics

    $146.5K

    Filed 25/11/26

  • Bradley L. Campbell

    Sell10b5-1 planAmicus Therapeutics

    $4,000

    Filed 25/02/21